Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/2106Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | REG NO: BI0122001 | - |
| dc.date.accessioned | 2026-02-24T06:00:41Z | - |
| dc.date.available | 2026-02-24T06:00:41Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/2106 | - |
| dc.description.abstract | Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disorder characterized by immune dysregulation and multi-organ involvement. Lupus nephritis (LN) is a severe complication of SLE, often requiring precise biomarkers for early detection and disease monitoring. IL- 12p40, a subunit of the pro-inflammatory cytokine IL-12, has emerged as a potential biomarker for LN, influencing Th1 immune responses and inflammation. Objective: ● To estimate IL-12 p40 level in urine among patients with lupus nephritis by ELISA to correlate the clinical presentation of SLE patients. ● To evaluate the association of variation of IL-12p40 levels with other biomarkers, in assessment of lupus nephritis. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | Systemic Lupus erythematosus, Lupus Nephritis, proteinuria, complement, Interleukin- 12 | en_US |
| dc.title | Evaluate urine il -12p40 levels in Different stages of lupus nephritis –One-year cross-sectional study | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | Microbiology | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| BI0122001.pdf | 2.64 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.